Rna Therapeutics Market Pipeline Analysis: By Clinical Trial Phase (Pre-clinical Phase, Phase-I, Phase-II, Phase-III), By Application (Cancer, Renal Disorders, Cardiovascular Disorders, Metabolic Disorders, Infectious Diseases, Others), By Route of Administration (Intravenous, Intradermal, Intraperitoneal, Pulmonary, Topical, Others), and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

RNA Therapeutics market estimated to be valued USD 5.8 billion in 2022 and is poised to grow at a CAGR of 18.8% from 2023-2029.  due to increase in prevalence of chronic diseases such as cancer and cardiovascular diseases, surge in number of biopharmaceutical and biotechnology industries, Â rise in funding for the development of RNA therapeutics from public and private sectors, promising pipeline drugs, and wide range of applications with RNA therapeutics are the major factors that are driving the growth of the global RNA therapeutics market over the forecast timeframe. Global RNA therapeutics pipeline analysis report gives comprehensive outlook on RNA therapeutics across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report on global RNA therapeutics market gives future market sizes (US$ Mn) on the basis of clinical trial phase, route of administration, and region. This report studies global RNA therapeutics dynamics elaborately to indentify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global RNA therapeutics market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global RNA therapeutics market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global RNA therapeutics market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in global RNA therapeutics products.  

Global Rna Therapeutics Pipeline Analysis Summary

Study Period

2023-2029

Base Year

2023

CAGR

N/A

Largest Market

North America

Fastest Growing Market

North America
RNA Therapeutics Pipeline Analysis Dynamics

ncrease in the prevalence of cancer, cardiovascular, and other chronic diseases is a key factor drive the global RNA therapeutics market. According to World Health Organization 2018, approximately 9.6 Mn death occurred due to cancer around the globe. Moreover, according to WHO, approximately 17.9 Mn deaths occurred due to cardiovascular disorders around the globe. In addition, target specificity and selectivity of RNAi therapeutics, more intense product focus versus platform technologies and virtual drug development models are anticipated to propel the global RNA therapeutics market over the forecast years. 

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Global Rna Therapeutics Pipeline Analysis Segmentation

By Clinical Trial Phase
  • Pre-clinical Phase
  • Phase-I
  • Phase-II
  • Phase-III
By Application
  • Cancer
  • Renal Disorders
  • Cardiovascular Disorders
  • Metabolic Disorders
  • Infectious Diseases
  • Others
By Route of Administration
  • Intravenous
  • Intradermal
  • Intraperitoneal
  • Pulmonary
  • Topical
  • Others

Frequently Asked Questions

The rna therapeutics pipeline analysis size was valued at USD 5.9 billion in 2022

Asia Pacific is the fastest-growing for rna therapeutics pipeline analysis

The key segments covered in the rna therapeutics pipeline analysis are: by clinical trial phase, application, route of administration and geography

 

  1. Executive Summary
  2. Global RNA Therapeutics Pipeline Analysis Introduction
    • Global RNA Therapeutics Pipeline Analysis Taxonomy
    • Global RNA Therapeutics Pipeline Analysis Definitions
      • Clinical Trial Phase
      • Application
      • Route of Administration
  1. Global RNA Therapeutics Pipeline Analysis Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global RNA Therapeutics Pipeline Analysis Dynamic Factors - Impact Analysis
    • Global RNA Therapeutics Pipeline Analysis Competition Landscape
  2. Global RNA Therapeutics Pipeline Analysis, 2018 - 2022 and Forecast, 2023 - 2029
    • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Opportunity Analysis
  3. Global RNA Therapeutics Pipeline Analysis, By Clinical Trial Phase, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Pre-Clinical Phase
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Phase-I
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Phase-II
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Phase-III
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global RNA Therapeutics Pipeline Analysis Forecast, By Application, 2018 - 2022 and Forecast, 2023 - 2029
    • Cancer
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Renal Disorders
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Cardiovascular Disorders
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Metabolic Disorders
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Infectious Diseases
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global RNA Therapeutics Pipeline Analysis Forecast, By Route of Administration, 2018 - 2022 and Forecast, 2023 - 2029
    • Intravenous
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Intradermal
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Intraperitoneal
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Pulmonary
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Topical
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global RNA Therapeutics Pipeline Analysis Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global RNA Therapeutics Pipeline Analysis - Opportunity Analysis Index, By Clinical Trial Phase, Application, Route of Administration, and Region, 2023 - 2029
  2. North America RNA Therapeutics Pipeline Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Clinical Trial Phase Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Pre-Clinical Phase
      • Phase-I
      • Phase-II
      • Phase-III
    • Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Cancer
      • Renal Disorders
      • Cardiovascular Disorders
      • Metabolic Disorders
      • Infectious Diseases
      • Others
    • Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Intravenous
      • Intradermal
      • Intraperitoneal
      • Pulmonary
      • Topical
      • Others
    • Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • US.
      • Canada
    • North America RNA Therapeutics Pipeline Analysis - Opportunity Analysis Index, By Clinical Trial Phase, Application, Route of Administration, and Country, 2023 - 2029
    • North America RNA Therapeutics Pipeline Analysis Dynamics Trends
  3. Europe RNA Therapeutics Pipeline Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Clinical Trial Phase Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Pre-Clinical Phase
      • Phase-I
      • Phase-II
      • Phase-III
    • Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Cancer
      • Renal Disorders
      • Cardiovascular Disorders
      • Metabolic Disorders
      • Infectious Diseases
      • Others
    • Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Intravenous
      • Intradermal
      • Intraperitoneal
      • Pulmonary
      • Topical
      • Others
    • Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe RNA Therapeutics Pipeline Analysis - Opportunity Analysis Index, By Clinical Trial Phase, Application, Route of Administration, and Country, 2023 - 2029
    • Europe RNA Therapeutics Pipeline Analysis Dynamics Trends
  4. Asia-Pacific RNA Therapeutics Pipeline Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Clinical Trial Phase Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Pre-Clinical Phase
      • Phase-I
      • Phase-II
      • Phase-III
    • Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Cancer
      • Renal Disorders
      • Cardiovascular Disorders
      • Metabolic Disorders
      • Infectious Diseases
      • Others
    • Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Intravenous
      • Intradermal
      • Intraperitoneal
      • Pulmonary
      • Topical
      • Others
    • Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific RNA Therapeutics Pipeline Analysis - Opportunity Analysis Index, By Clinical Trial Phase, Application, Route of Administration, and Country, 2023 - 2029
    • Asia-Pacific RNA Therapeutics Pipeline Analysis Dynamics Trends
  5. Latin America RNA Therapeutics Pipeline Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Clinical Trial Phase Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Pre-Clinical Phase
      • Phase-I
      • Phase-II
      • Phase-III
    • Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Cancer
      • Renal Disorders
      • Cardiovascular Disorders
      • Metabolic Disorders
      • Infectious Diseases
      • Others
    • Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Intravenous
      • Intradermal
      • Intraperitoneal
      • Pulmonary
      • Topical
      • Others
    • Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America RNA Therapeutics Pipeline Analysis - Opportunity Analysis Index, By Clinical Trial Phase, Application, Route of Administration, and Country, 2023 - 2029
    • Latin America RNA Therapeutics Pipeline Analysis Dynamics Trends
  6. Middle East and Africa RNA Therapeutics Pipeline Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Clinical Trial Phase Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Pre-Clinical Phase
      • Phase-I
      • Phase-II
      • Phase-III
    • Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Cancer
      • Renal Disorders
      • Cardiovascular Disorders
      • Metabolic Disorders
      • Infectious Diseases
      • Others
    • Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Intravenous
      • Intradermal
      • Intraperitoneal
      • Pulmonary
      • Topical
      • Others
    • Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA RNA Therapeutics Pipeline Analysis - Opportunity Analysis Index, By Clinical Trial Phase, Application, Route of Administration, and Country, 2023 - 2029
    • MEA RNA Therapeutics Pipeline Analysis Dynamics Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Clinical Trial Phase & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Moderna, Inc.
      • CureVac AG
      • BioNTech AG
      • Alnylam Pharmaceuticals, Inc.
      • Arbutus Biopharma Corporation
      • miRagen Therapeutics, Inc
  8. Research Methodology
  • Moderna, Inc.
  • CureVac AG
  • BioNTech AG
  • Alnylam Pharmaceuticals, Inc.
  • Arbutus Biopharma Corporation
  • miRagen Therapeutics, Inc.

Adjacent Markets